Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Non Operating Income (2022 - 2026)

Envoy Medical's Non Operating Income history spans 5 years, with the latest figure at $1.6 million for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 14718.18% to $1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $792000.0, a 148.8% increase, with the full-year FY2025 number at -$1.5 million, up 3.44% from a year prior.
  • Non Operating Income hit $1.6 million in Q1 2026 for Envoy Medical, up from -$201000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for COCH hit a ceiling of $11.7 million in Q4 2023 and a floor of -$8.8 million in Q2 2023.
  • Historically, Non Operating Income has averaged -$157866.7 across 5 years, with a median of -$11000.0 in 2025.
  • Biggest five-year swings in Non Operating Income: crashed 1420.0% in 2024 and later soared 14718.18% in 2026.
  • Tracing COCH's Non Operating Income over 5 years: stood at -$8.6 million in 2022, then skyrocketed by 236.23% to $11.7 million in 2023, then tumbled by 113.1% to -$1.5 million in 2024, then soared by 86.85% to -$201000.0 in 2025, then skyrocketed by 900.0% to $1.6 million in 2026.
  • Business Quant data shows Non Operating Income for COCH at $1.6 million in Q1 2026, -$201000.0 in Q4 2025, and $5000.0 in Q3 2025.